Virginia Retirement Systems’s Intellia Therapeutics NTLA Stock Holding History

Virginia Retirement Systems’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Sell	20,242 -1,100	-5%	-$15.4K	﹤0.01%	1085
2026 Q1	$274K	Hold	21,342	–	–	﹤0.01%	863
2025 Q4	$192K	Buy	21,342 +4,600	+27%	+$63.3K	﹤0.01%	919
2025 Q3	$289K	Sell	16,742 -1,000	-6%	-$12.3K	﹤0.01%	847
2025 Q2	$166K	Buy	17,742 +900	+5%	+$7.39K	﹤0.01%	912
2025 Q1	$120K	Buy	+16,842	New	+$170K	﹤0.01%	991
2023 Q3	–	Sell	-8,600	Closed	-$351K	–	1004
2023 Q2	$351K	Buy	8,600 +1,700	+25%	+$68.9K	﹤0.01%	806
2023 Q1	$257K	Buy	+6,900	New	+$271K	﹤0.01%	914
2022 Q1	–	Sell	-4,200	Closed	-$497K	–	1189
2021 Q4	$497K	Sell	4,200 -4,800	-53%	-$601K	﹤0.01%	855
2021 Q3	$1.21M	Sell	9,000 -1,000	-10%	-$151K	0.01%	555
2021 Q2	$1.62M	Sell	10,000 -1,500	-13%	-$117K	0.02%	487
2021 Q1	$923K	Buy	11,500 +2,000	+21%	+$134K	0.01%	687
2020 Q4	$517K	Buy	+9,500	New	+$345K	0.01%	835

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Virginia Retirement Systems's NTLA Position: Q2 2026 in Review

Virginia Retirement Systems reduced its Intellia Therapeutics (NTLA) stake by 5.2% in Q2 2026, selling an estimated $15.4K and leaving 20,242 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Virginia Retirement Systems first reported a position in NTLA in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.62M in Q2 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

Virginia Retirement Systems held 20,242 shares of Intellia Therapeutics worth $342K as of Q2 2026.
Virginia Retirement Systems sold 1,100 Intellia Therapeutics shares in Q2 2026, an estimated $15.4K.
Intellia Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1085 holding.
Virginia Retirement Systems first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 13 quarters since.
Virginia Retirement Systems's Intellia Therapeutics position peaked at $1.62M in Q2 2021.
328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.